Literature DB >> 32533818

MAPK: A Key Player in the Development and Progression of Stroke.

Yangmin Zheng1,2, Ziping Han1,2, Haiping Zhao1,2, Yumin Luo1,2,3.   

Abstract

Stroke is a complex disease caused by genetic and environmental factors, and its etiological mechanism has not been fully clarified yet, which brings great challenges to its effective prevention and treatment. MAPK signaling pathway regulates gene expression of eukaryotic cells and basic cellular processes such as cell proliferation, differentiation, migration, metabolism and apoptosis, which are considered as therapeutic targets for many diseases. Up to now, mounting evidence has shown that MAPK signaling pathway is involved in the pathogenesis and development of ischemic stroke. However, the upstream kinase and downstream kinase of MAPK signaling pathway are complex and the influencing factors are numerous, the exact role of MAPK signaling pathway in the pathogenesis of ischemic stroke has not been fully elucidated. MAPK signaling molecules in different cell types in the brain respond variously after stroke injury, therefore, the present review article is committed to summarizing the pathological process of different cell types participating in stroke, discussed the mechanism of MAPK participating in stroke. We further elucidated that MAPK signaling pathway molecules can be used as therapeutic targets for stroke, thus promoting the prevention and treatment of stroke. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Ischemic stroke; MAPK pathway; different cell types; inflammation; neuroprotection; oxidative stress

Year:  2020        PMID: 32533818     DOI: 10.2174/1871527319666200613223018

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  7 in total

1.  Estrogen-related Receptor α (ERRα) Functions in The Hypoxic Injury of Microglial Cells.

Authors:  Chao-Yang Deng; Ting-Ting Zhu; Shuai Lian; Jian-Fa Wang; Rui Wu; Jia-San Zheng
Journal:  J Vet Res       Date:  2022-03-10       Impact factor: 2.058

Review 2.  The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.

Authors:  Xing-Hua Li; Feng-Ting Yin; Xiao-Hang Zhou; Ai-Hua Zhang; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  Molecules       Date:  2022-05-12       Impact factor: 4.927

3.  Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis.

Authors:  Kumaran Sundaram; Jingyao Mu; Anil Kumar; Jyotirmaya Behera; Chao Lei; Mukesh K Sriwastva; Fangyi Xu; Gerald W Dryden; Lifeng Zhang; ShaoYu Chen; Jun Yan; Xiang Zhang; Juw Won Park; Michael L Merchant; Neetu Tyagi; Yun Teng; Huang-Ge Zhang
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

4.  To explore the Radix Paeoniae Rubra-Flos Carthami herb pair's potential mechanism in the treatment of ischemic stroke by network pharmacology and molecular docking technology.

Authors:  Xingyu Chen; Yue Wang; Ying Ma; Ruonan Wang; Dexi Zhao
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

5.  Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway.

Authors:  Zhanwei Fan; Jianjiang Dong; Yindong Mu; Xian Liu
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

6.  Brain Protective Effect of Resveratrol via Ameliorating Interleukin-1β-Induced MMP-9-Mediated Disruption of ZO-1 Arranged Integrity.

Authors:  Ming-Ming Tsai; Jiun-Liang Chen; Tsong-Hai Lee; Hsiuming Liu; Velayuthaprabhu Shanmugam; Hsi-Lung Hsieh
Journal:  Biomedicines       Date:  2022-05-29

7.  Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling pathway.

Authors:  Yan Wang; Jiaxin Liu; Baocong Yu; Yiran Jin; Jiahui Li; Xiaona Ma; Jianqiang Yu; Jianguo Niu; Xueyun Liang
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.